Followers | 9839 |
Posts | 260002 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Friday, June 02, 2017 5:18:11 PM
Link to Video - click here to watch the technical chart video
Recent XBIT News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:36:43 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:01:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 03:48:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 02:00:25 PM
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis • GlobeNewswire Inc. • 11/14/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:41:46 PM
- XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke • GlobeNewswire Inc. • 09/26/2023 01:00:00 PM
- XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer • GlobeNewswire Inc. • 08/30/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 03:18:47 PM
- XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial • GlobeNewswire Inc. • 08/08/2023 03:47:05 PM
- FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients • GlobeNewswire Inc. • 05/22/2023 01:00:00 PM
- XBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares • GlobeNewswire Inc. • 05/17/2023 01:00:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM